Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
08/2003
08/28/2003WO2001096875A3 Hcv antigen/antibody combination assay
08/28/2003WO2001092307A3 Therapeutic compounds for ovarian cancer
08/28/2003US20030163846 Process for the genetic modification of a plant
08/28/2003US20030163845 Elongase genes and uses thereof
08/28/2003US20030163841 Better emergence characteristics and improved seedling growth under low-light environments
08/28/2003US20030163840 Genetic engineering; modulation Dna metabolism
08/28/2003US20030163836 In situ detection of enzyme inhibitors
08/28/2003US20030163834 Erk-5 deficient animals and methods of inhibiting angiogenesis through the inhibition of Erk-5
08/28/2003US20030163342 Method for defraying storage costs
08/28/2003US20030162954 Antitumor agents; gastrointestinal disorders
08/28/2003US20030162947 Rapid production of monoclonal antibodies
08/28/2003US20030162946 Isolated human G-protein coupled receptors, nucleic acid molecules encoding human GPCR proteins, and uses thereof
08/28/2003US20030162944 Nucleic acid encoding neuropeptide Y/peptide YY (Y2) receptors and uses thereof
08/28/2003US20030162736 Medicament comprising NK4 gene or recombinant NK4 protein
08/28/2003US20030162720 Therapeutic anti-HIV (IV9) compounds
08/28/2003US20030162714 Modulate cell differentiation; muscular disorders; fat metabolism; bone disorders
08/28/2003US20030162709 Methods of generating multispecific, multivalent agents from VH and VL domains
08/28/2003US20030162294 Genes involved in tolerance to environmental stress
08/28/2003US20030162291 Clk-2, cex-7 and coq-4 genes, and uses thereof
08/28/2003US20030162290 Method for inducing differentiation of embryonic stem cells into functioning cells
08/28/2003US20030162289 Peptides promoting cell adherence, growth and secretion
08/28/2003US20030162287 Carrier for cell culture and method for culturing cells
08/28/2003US20030162278 Use for development of human therapeutic proteins; amino acid sequences, allelic variants, isolated polypeptide, antibody and nucleic acids, transgenic non-human animal, culturing the host cell, genetic engineering
08/28/2003US20030162274 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
08/28/2003US20030162256 PTH1R and PTH3R receptors, methods and uses thereof
08/28/2003US20030162250 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/28/2003US20030162249 Providing a culture of bacterial cells, adding rhanmose to the culture to induce rhamnose promoter whereby the antibody heavy chain and light chain and their linked signal sequences are expressed, secreted to the periplasm
08/28/2003US20030162205 Novel transcription factor having zinc finger domain
08/28/2003US20030162176 Complementary DNAs
08/28/2003US20030162175 NK cell receptor polynucleotides, polypeptides, and antibodies
08/28/2003US20030162169 Screening enzyme inhibitors
08/28/2003US20030162168 Surrogate cell-based system and method for assaying the activity of hepatitis C virus NS3 protease
08/28/2003US20030162167 Hepatitis c virusl detection using Dna sequences; liver disorders; immunoassay
08/28/2003US20030161845 A chimeric Arterivirus composed of parts originating from at least two different arteriviruses where a stretch of nucleic acids encoding a non-Arteriviris protein fragment is inserted in the full genome; vaccines; veterinary medicine; swine
08/28/2003US20030161836 Biological materials and methods useful in the diagnosis and treatment of diseases
08/28/2003US20030161833 Chlamydia antigens and corresponding DNA fragments and uses thereof
08/28/2003US20030161819 Genetic engineering; promoters; deactivation of major histocompatibility complex
08/28/2003US20030161818 Cultures, products and methods using stem cells
08/28/2003US20030161817 Pluripotent embryonic-like stem cells, compositions, methods and uses thereof
08/28/2003US20030161816 Systems and methods for treating patients with processed lipoaspirate cells
08/28/2003US20030161815 Cell delivery system
08/28/2003US20030161813 Altering the properties of cells or of particles with membranes derived from cells by means of lipid-modified proteinaceous molecules
08/28/2003CA2775650A1 Decreased reducing sugars in plants for the reduction of acrylamide production in heated foods
08/28/2003CA2486388A1 Novel fungal lipase
08/28/2003CA2477195A1 Deleted sequence in m. tuberculosis, method for detecting mycobacteria using these sequences and vaccines
08/28/2003CA2477012A1 Anti-a.beta. antibodies and their use
08/28/2003CA2476917A1 Artificial vessel scaffold and artificial organs therefrom
08/28/2003CA2476625A1 Mhc-peptide complex binding ligands
08/28/2003CA2476376A1 Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells
08/28/2003CA2475540A1 Heat stable mutants of starch biosynthesis enzymes
08/28/2003CA2475437A1 Methods for producing .gamma..delta. t cells
08/28/2003CA2475188A1 Mismatch repair detection
08/28/2003CA2473133A1 Rrp sequences and knockout mice and uses thereof
08/28/2003CA2473132A1 Vaccination and vaccine and drug delivery by topical application of vectors and vector extracts recombinant vectors, and noninvasive genetic immunization, expression products therefrom,and uses thereof
08/28/2003CA2460055A1 Insulin and igf-1 receptor agonists and antagonists
08/28/2003CA2373903A1 Increasing plant seed production
08/27/2003EP1338657A1 Sequences specifcally deleted from Mycobacterium tuberculosis genome and their use in diagnosistics and as vaccines
08/27/2003EP1338653A2 Improvement of an expression vector for production of recombinant proteins
08/27/2003EP1338648A1 Pharmaceutically acceptable fixed-dried human blood platelets
08/27/2003EP1338285A1 Plasmagel
08/27/2003EP1338198A1 Method of constructing mouse suitable for the take, differentiation and proliferation of heterogenous cells, mouse constructed by this method and use of the mouse
08/27/2003EP1337850A1 Method for diagnosing a tumor in a patient determining the concentration of pibf
08/27/2003EP1337664A2 Method for introducing antisense oligonucleotides into eucaryotic cells
08/27/2003EP1337655A2 Retroviral vectors containing internal ribosomal entry sites
08/27/2003EP1337650A1 Transgenic animals for analysing cyp3a4 cytochrome p450 gene regulation
08/27/2003EP1337646A2 Genes of the 1-desoxy-d-xylulose biosynthesis path
08/27/2003EP1337644A2 Aspergillus fumigatus profilin
08/27/2003EP1337641A2 Flea gaba receptor subunit nucleic acid molecules, proteins and uses thereof
08/27/2003EP1337640A2 NOVEL RETINA-SPECIFIC HUMAN PROTEINS C7orf9, C12orf7, MPP4 AND F379
08/27/2003EP1337639A2 Master bone formation transcription factor: compositions and methods of use
08/27/2003EP1337638A2 Adipocyte complement related protein zacrp13
08/27/2003EP1337636A2 Soluble zcytor 11 cytokine receptors
08/27/2003EP1337634A2 Novel polypeptides involved in immune response
08/27/2003EP1337632A2 Differentiated cells suitable for human therapy
08/27/2003EP1337631A2 Eukaryotic expression libraries based on double lox recombination and methods of use
08/27/2003EP1337625A2 Stem cells, method for expansion in vitro and use thereof
08/27/2003EP1337624A2 Cell constructs which can be obtained from mesenschymal stem cells and cells derivable therefrom and the use thereof
08/27/2003EP1337558A2 A "bach" g protein coupled receptor polypeptide and polynucleotide encoding this receptor
08/27/2003EP1337556A2 Mutated immunogenic peptides derived from r9m, polynucleotides coding for same and therapeutic uses thereof
08/27/2003EP1337544A2 Polynucleotide encoding an activated human t-lymphocyte-derived protein related to ubiquitin conjugating enzyme
08/27/2003EP1337282A2 Type ii gonadotropin-releasing hormone receptor and polynucleotides encoding therefor
08/27/2003EP1337276A2 Artery smooth muscle- and vein smooth muscle-specific proteins and uses therefor
08/27/2003EP1337152A2 Methods of utilizing cultured non-gvhd inducing t lymphocytes to treat disease
08/27/2003EP1267834A4 Cationic liposomes
08/27/2003EP1187921A4 Compositions affecting programmed cell death and their use in the modification of forestry plant development
08/27/2003EP1140938B1 High affinity inhibitors for target validation and uses thereof
08/27/2003EP1124577B1 USE OF AN ENTEROBACTERIUM PROTEIN OmpA FOR SPECIFIC TARGETING TOWARDS ANTIGEN-PRESENTING CELLS
08/27/2003EP1112077A4 Method for detection of biological factors in epidermis
08/27/2003EP1098958B1 Method for providing a substrate structure for oriented neurite outgrowth, substrate structure, and device for monitoring neurons
08/27/2003EP1042368B1 Antibodies against phosphorylated vasp (vasodilator-stimulated phosphoprotein), hybridoma cells for their preparation, and their use
08/27/2003EP1030697B1 Biodegradable polymer scaffold
08/27/2003EP0932625B1 Monoclonal antibodies against the ypydvpdya epitope, process for producing the same and their use
08/27/2003EP0909277B1 Humanized antibodies that bind to the same antigen as bound by antibody nr-lu-13, and their use in pretargeting methods
08/27/2003EP0830600B1 Functional bioassay for g-protein coupled receptor agonists and antagonists
08/27/2003EP0795008B1 Human hypertrophic chondrocyte cell-lines
08/27/2003EP0764047B1 Polymeric microbeads and method of preparation
08/27/2003EP0750458B1 Terminal complement inhibitor fusion genes and proteins
08/27/2003CN1439050A Method for producing recipient-specific tissue transplant or tissue implant
08/27/2003CN1439049A Hepatocyte lineage cells derived from pluripotent stem cells
08/27/2003CN1439022A Human monoclonal antibody against a costimulatory signal transduction molecule AILIM and pharmaceutical use thereof
1 ... 1175 1176 1177 1178 1179 1180 1181 1182 1183 1184 1185 1186 1187 1188 1189 1190 1191 1192 1193 1194 1195 ... 1827